| Website | seroba-kernel.com |
| Phone | +353 (0)1 6334028 |
| Employees |
Seroba Kernel Life Sciences Limited (Seroba Kernel) is a European life science venture capital firm with total funds under management of €100m. The firm had a €75 million first close of its second fund in 2009 which will invest in life science companies in Ireland, the United Kingdom and other parts of Europe.
Seroba Kernel invests across the spectrum of the life science industry including biotechnology, specialty pharmaceuticals, medical technology, diagnostics, instrumentation and other selected opportunities within the sector that have the potential to fundamentally change medical care.
Seroba Kernel has an experienced venture team based in Dublin and London. The principals in the firm have complementary skill sets and have held senior management positions across the international life science, financial and venture capital industries, in Europe and North America.
| Company | Date | Round | Size | Participants |
| Novate Medical | 5/11 | Series B | €8.7M | 4 |
| Provesica | 12/10 | Venture Round | €4.7M | 1 |
| Covagen | 11/10 | Series A | $6.3M | 5 |
| Veryan Medical | 4/10 | Series B | $5.4M | 4 |
| Quanta Fluid Solutions | 11/09 | Series A | $14.3M | 4 |
| Opsona | 6/09 | Series B | $4.6M | 6 |
| Biosensia | 2/08 | Venture Round | $2.93M | 4 |
| Diabetica | 6/05 | Series A | $1.21M | 2 |
